CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 81 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $752,729 | -13.1% | 128,892 | -0.3% | 0.00% | – |
| Q3 2022 | $866,000 | +111.2% | 129,334 | +33.0% | 0.00% | – |
| Q2 2022 | $410,000 | +22.8% | 97,235 | -2.0% | 0.00% | – |
| Q1 2022 | $334,000 | +5.4% | 99,232 | -1.3% | 0.00% | – |
| Q4 2021 | $317,000 | -7.8% | 100,558 | -4.4% | 0.00% | – |
| Q3 2021 | $344,000 | -27.3% | 105,180 | -6.0% | 0.00% | – |
| Q2 2021 | $473,000 | -71.9% | 111,840 | -66.9% | 0.00% | – |
| Q1 2021 | $1,684,000 | -66.3% | 337,612 | -14.5% | 0.00% | -100.0% |
| Q4 2020 | $4,994,000 | +25.3% | 395,097 | -2.7% | 0.00% | 0.0% |
| Q3 2020 | $3,986,000 | -3.0% | 405,943 | -1.7% | 0.00% | 0.0% |
| Q2 2020 | $4,108,000 | +39.0% | 412,807 | +23.4% | 0.00% | 0.0% |
| Q1 2020 | $2,956,000 | +13.1% | 334,429 | +18.0% | 0.00% | 0.0% |
| Q4 2019 | $2,614,000 | +46.9% | 283,301 | -6.4% | 0.00% | – |
| Q3 2019 | $1,779,000 | -49.9% | 302,514 | +2.3% | 0.00% | -100.0% |
| Q2 2019 | $3,549,000 | +1.0% | 295,756 | +1.6% | 0.00% | 0.0% |
| Q1 2019 | $3,513,000 | -3.8% | 291,071 | +0.1% | 0.00% | 0.0% |
| Q4 2018 | $3,651,000 | -48.5% | 290,921 | -39.2% | 0.00% | -50.0% |
| Q3 2018 | $7,096,000 | -37.4% | 478,190 | -29.0% | 0.00% | -33.3% |
| Q2 2018 | $11,335,000 | -22.2% | 673,466 | +5.9% | 0.00% | -25.0% |
| Q1 2018 | $14,567,000 | +28.9% | 636,097 | +45.6% | 0.00% | +33.3% |
| Q4 2017 | $11,305,000 | +228.7% | 437,007 | +87.4% | 0.00% | +200.0% |
| Q3 2017 | $3,439,000 | +1.1% | 233,201 | -4.4% | 0.00% | 0.0% |
| Q2 2017 | $3,403,000 | -9.1% | 243,989 | +11.2% | 0.00% | 0.0% |
| Q1 2017 | $3,742,000 | +66.2% | 219,367 | +0.2% | 0.00% | 0.0% |
| Q4 2016 | $2,252,000 | +5.6% | 218,844 | +3.8% | 0.00% | 0.0% |
| Q3 2016 | $2,132,000 | -9.5% | 210,923 | +0.6% | 0.00% | 0.0% |
| Q2 2016 | $2,356,000 | -27.6% | 209,754 | -11.9% | 0.00% | 0.0% |
| Q1 2016 | $3,253,000 | -8.0% | 238,125 | +27.8% | 0.00% | 0.0% |
| Q4 2015 | $3,536,000 | +5.4% | 186,387 | +4.3% | 0.00% | 0.0% |
| Q3 2015 | $3,354,000 | +358.8% | 178,687 | +264.2% | 0.00% | – |
| Q2 2015 | $731,000 | +147.8% | 49,065 | +152.1% | 0.00% | – |
| Q1 2015 | $295,000 | +86.7% | 19,466 | +64.0% | 0.00% | – |
| Q4 2014 | $158,000 | +5.3% | 11,872 | 0.0% | 0.00% | – |
| Q3 2014 | $150,000 | -76.9% | 11,872 | -81.5% | 0.00% | – |
| Q2 2014 | $648,000 | +82.5% | 64,242 | +143.3% | 0.00% | – |
| Q1 2014 | $355,000 | – | 26,401 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
| Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
| Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
| EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
| BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
| EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
| RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
| Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
| AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
| INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |